The first shot felt like a miracle. You got your walk back, your sleep back, the sense that the problem was solvable. The second did a little less. Now you are spacing them out, stretching each one further, and quietly dreading the appointment where the answer is that there is nothing left to give.
That trajectory is not a failure of your hip and it is not a failure of your imagination. The diminishing returns are built into what the shot does.
Why the curve bends downward
A steroid injection into a hip is doing one thing: suppressing an inflammatory signal. When it works, it works impressively, because a large amount of what you were feeling was signal.
But suppression is not repair. The joint’s underlying condition is not altered by the injection — only your perception of it is. So the disease process continues along its own path while the relief is temporary by design.
Each subsequent shot therefore starts from a worse baseline than the one before it. The same intervention, applied to a joint further along, produces a smaller and shorter effect. That is the entire shape of the curve you have been living, and it is predictable rather than mysterious.
What a two-year trial found
There is more to it than a fading effect, and this is the part that most patients are never told.
In a two-year randomized controlled trial, patients receiving steroid injections every three months had greater cartilage loss than those receiving saline — and no pain improvement over the two years.
Sit with both halves of that. The injections were associated with more cartilage loss than an inert comparison. And across the full two years, they did not deliver better pain outcomes than the inert comparison either.
The implication for your hip is direct. Each shot taken to feel better may be quietly accelerating the very degeneration that is causing your pain. The relief is real in the moment. The trade being made is not the one most patients believe they are making.
Why it is still the default
If the two-year data is that unfavorable, the obvious question is why the injection remains the standard offering.
The answer is structural, not personal. Steroid injection is fast, inexpensive, reimbursed, and produces an immediate and visible effect — the patient leaves feeling better, and the encounter is complete. It fits the format of a short visit and a defined billing code. An approach that requires measurement, metabolic assessment, and a longer arc does not fit that format at all.
Dr. Padda has performed thousands of these injections. That experience is worth stating precisely because it makes the point non-ideological: this is not a critique from someone unfamiliar with the tool. It is an observation about what the tool does over years, from someone who has used it extensively and watched the curve bend in patient after patient.
Working with the tissue instead of wearing it down
The regenerative alternative starts from a different objective. Instead of suppressing the signal a degenerating hip is producing, the aim is to work with the tissue rather than against it — to address the joint’s actual condition rather than its expression.
That shift changes what success looks like. A steroid injection is evaluated by how quickly and how completely the pain went away. A regenerative approach is evaluated by whether the joint’s trajectory changed, which is a slower and less immediately gratifying measurement.
It is also why the goal is not a better shot. The goal is a hip that does not need one.
Whether that is achievable in your case depends on the current state of your joint, your metabolic terrain, and factors that require examination and imaging to establish. It is not something an article can determine. What an article can tell you is that the question is worth asking before the next injection rather than after it.
Frequently asked questions
Should I cancel my next cortisone injection?
No. Do not start, stop, or change any treatment without consulting your physician. If what you have read here raises questions, bring them to the physician who knows your hip, or seek a formal second evaluation before your next appointment. This page is information to inform that conversation, not a directive to cancel care.
I have already had several shots. Have I done permanent damage?
Not necessarily, and the honest answer is that it depends on the current state of your joint — which can be assessed rather than assumed. What is more actionable now is the decision in front of you: whether to continue a cycle that has already demonstrated diminishing returns, or to have the hip properly evaluated first.
Is cortisone ever appropriate?
Yes. There are situations where suppressing an inflammatory signal is clinically appropriate, and a steroid can serve as a rare, strategic step. The concern raised here is specific to repetition — injections every three months over years, with the cartilage and pain outcomes the two-year trial reported.
How quickly would a regenerative approach work compared with a shot?
Slower, and that is the trade. A steroid injection produces fast relief that fades; an approach aimed at the tissue itself asks for patience in exchange for a different trajectory. Individual results vary, and not every patient is a candidate for the therapies described.
Key takeaways
- Diminishing returns from repeated hip injections are predictable, because suppression does not change the joint’s underlying condition.
- In a two-year randomized controlled trial, steroid injections every three months produced greater cartilage loss than saline.
- That same trial showed no pain improvement over the two years compared with saline.
- The injection remains the default because it is fast, inexpensive, and fits a short-visit model — not because the long-term data supports repetition.
- The objective worth pursuing is not a better shot but a hip that does not require one.
Medically reviewed by Gurpreet Singh Padda, MD, MBA, MHP — Board Certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.
This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary, and not every patient is a candidate for the therapies described. Do not start, stop, or change any treatment without consulting your physician. Orthobiologic therapies are not FDA-approved for this indication and are provided as part of physician-directed care.
Find out what is actually driving your pain
Regen.MD begins with a physician-led Clinical Evaluation — a review of your history, imaging, and metabolic data, and a written terrain roadmap. Evaluation is contingent upon review of your data.
Questions? Call (314) 668-1525 or text (314) 886-5902.

Leave a Reply